Review



urine albumin concentration  (Assaypro)


Bioz Verified Symbol Assaypro is a verified supplier
Bioz Manufacturer Symbol Assaypro manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Assaypro urine albumin concentration
    Urine Albumin Concentration, supplied by Assaypro, used in various techniques. Bioz Stars score: 94/100, based on 55 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentration/product/Assaypro
    Average 94 stars, based on 55 article reviews
    urine albumin concentration - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    Chondrex Inc urine albumin concentrations
    Urine Albumin Concentrations, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentrations/product/Chondrex Inc
    Average 94 stars, based on 1 article reviews
    urine albumin concentrations - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Assaypro urine albumin concentration
    Urine Albumin Concentration, supplied by Assaypro, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentration/product/Assaypro
    Average 94 stars, based on 1 article reviews
    urine albumin concentration - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Bethyl mouse urine albumin concentration
    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal <t>mouse</t> without any treat ment was dedicated as control group. (B) Albuminuria <t>(urine</t> <t>albumin-to-creatinine</t> ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated
    Mouse Urine Albumin Concentration, supplied by Bethyl, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse urine albumin concentration/product/Bethyl
    Average 96 stars, based on 1 article reviews
    mouse urine albumin concentration - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Bethyl urine albumin concentration
    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal <t>mouse</t> without any treat ment was dedicated as control group. (B) Albuminuria <t>(urine</t> <t>albumin-to-creatinine</t> ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated
    Urine Albumin Concentration, supplied by Bethyl, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentration/product/Bethyl
    Average 96 stars, based on 1 article reviews
    urine albumin concentration - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Randox urine albumin concentrations
    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal <t>mouse</t> without any treat ment was dedicated as control group. (B) Albuminuria <t>(urine</t> <t>albumin-to-creatinine</t> ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated
    Urine Albumin Concentrations, supplied by Randox, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentrations/product/Randox
    Average 96 stars, based on 1 article reviews
    urine albumin concentrations - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    srl inc albumin and creatinine concentrations from spot urine samples
    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal <t>mouse</t> without any treat ment was dedicated as control group. (B) Albuminuria <t>(urine</t> <t>albumin-to-creatinine</t> ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated
    Albumin And Creatinine Concentrations From Spot Urine Samples, supplied by srl inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/albumin and creatinine concentrations from spot urine samples/product/srl inc
    Average 90 stars, based on 1 article reviews
    albumin and creatinine concentrations from spot urine samples - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Bethyl urine albumin concentrations
    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal <t>mouse</t> without any treat ment was dedicated as control group. (B) Albuminuria <t>(urine</t> <t>albumin-to-creatinine</t> ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated
    Urine Albumin Concentrations, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urine albumin concentrations/product/Bethyl
    Average 94 stars, based on 1 article reviews
    urine albumin concentrations - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal mouse without any treat ment was dedicated as control group. (B) Albuminuria (urine albumin-to-creatinine ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated

    Journal: Journal of nanobiotechnology

    Article Title: TRPC6-targeted dexamethasone nanobubbles with ultrasound-guided theranostics for adriamycin-induced nephropathy.

    doi: 10.1186/s12951-025-03487-8

    Figure Lengend Snippet: Fig. 5 In vivo therapeutic effects of Dex@NBs-TRPC6. (A) Schematic diagram of in vivo treatment and therapy protocol. Normal mouse without any treat ment was dedicated as control group. (B) Albuminuria (urine albumin-to-creatinine ratio) was determined in control group, ADR + NS group and three Dex-treated ADR groups. n = 9–10 mice per group. (C) Representative kidney images of PAS staining. Upper: glomerular morphology, scale bar = 20 μm; Lower: tubule-interstitial morphology, scale bar = 50 μm. (D) Quantitative analysis of glomerulosclerosis severity. (E) Quantitative analysis of tubular injury. (F) RT-PCR analysis of mRNA expression of Kim-1. (G) RT-PCR analysis of mRNA expression of NGAL. n = 9. (H) Representative images of TEM of glomerular basement membrane. Top: scale bar = 2 μm, Bottom: scale bar = 500 nm. (I) Quantitative analysis of foot process width. n = 6 mice per group in all histo logical analysis. (J) Upper: immunofluorescence staining of WT1 expressed in nuclei of mouse podocytes, scale bar = 20 μm. Lower: immunofluorescence staining of podocin expressed along the glomerular basement membrane, scale bar = 20 μm. (K) Quantitative analysis of WT1 positive cell numbers per glomerulus, n = 6. (L) Quantitative analysis of fluorescence intensity of podocin, n = 6. Data are presented as mean ± SEM, one-way ANOVA. *p < 0.05, **p < 0.01, vs. Control group, #p < 0.05, ##p < 0.01, vs. ADR + NS group, $p < 0.05, $$p < 0.01 as indicated

    Article Snippet: Mouse urine albumin concentration was measured using an ELISA kit (Bethyl Laboratories.

    Techniques: In Vivo, Control, Staining, Reverse Transcription Polymerase Chain Reaction, Expressing, Membrane, Immunofluorescence, Fluorescence